<?xml version="1.0" encoding="UTF-8"?>
<p>Despite the growing success of conventional personalized cancer therapies, recurrence and metastases remain common, depending on the type of cancer and the stage of disease (
 <xref rid="B37" ref-type="bibr">Miller et al., 2019</xref>). In addition, a large number of patients are diagnosed when in advanced stages, leaving little treatment options but for palliative care (
 <xref rid="B26" ref-type="bibr">Haun et al., 2017</xref>).
</p>
